Structure Therapeutics Inc - American Depositary Shares — Cash Flow (NASDAQ:GPCR) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -79.49 M-116.64 M222.2 M -93.37 M Cash from investing activities -268.34 M-358.91 M89.8 M 89.8 M Cash from financing activities 451.53 M515.26 M762.52 M 762.52 M Free cash flow -81.66 M-117.93 M218.59 M -96.98 M

Notizie

Le azioni Structure Therapeutics potrebbero salire sui dati del farmaco per l’obesità, afferma Cantor

Structure Therapeutics shares could rise on obesity drug data, Cantor says

Citizens riduce il target di prezzo di Structure Therapeutics per l’espansione della pipeline

Citizens cuts Structure Therapeutics stock price target on pipeline expansion

Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?

Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026

Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin

Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)

Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?

How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report

Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026

Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown